Approval · Notice of Compliance 14396 · 2013
AXUM: Notice of Compliance 14396
Issued May 24, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14396
- Date
- May 24, 2013
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Muscle relaxant; analgesic
- Canadian reference product
- ROBAX PLATINUM (Wyeth Consumer Healthcare Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AXUM | 02342197 | Cancelled Post Market |
Medicinal ingredients
- IBUPROFEN 200 MG per TAB
- METHOCARBAMOL 500 MG per TAB